These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

256 related items for PubMed ID: 16367740

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22. Coimmunization with an optimized IL15 plasmid adjuvant enhances humoral immunity via stimulating B cells induced by genetically engineered DNA vaccines expressing consensus JEV and WNV E DIII.
    Ramanathan MP, Kutzler MA, Kuo YC, Yan J, Liu H, Shah V, Bawa A, Selling B, Sardesai NY, Kim JJ, Weiner DB.
    Vaccine; 2009 Jul 09; 27(32):4370-80. PubMed ID: 19497647
    [Abstract] [Full Text] [Related]

  • 23.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 24. Hepatitis B virus precore protein augments genetic immunizations of the truncated hepatitis C virus core in BALB/c mice.
    Liao G, Wang Y, Chang J, Bian T, Tan W, Sun M, Li W, Yang H, Chen J, Zhang X, Bi S, Omata M, Jiang S.
    Hepatology; 2008 Jan 09; 47(1):25-34. PubMed ID: 18074356
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Recombinant in vitro assembled hepatitis C virus core particles induce strong specific immunity enhanced by formulation with an oil-based adjuvant.
    Acosta-Rivero N, Poutou J, Alvarez-Lajonchere L, Guerra I, Aguilera Y, Musacchio A, Rodríguez A, Aguilar JC, Falcon V, Alvarez-Obregon JC, Soria Y, Torres D, Linares M, Pérez A, Morales-Grillo J, Dueñas-Carrera S.
    Biol Res; 2009 Jan 09; 42(1):41-56. PubMed ID: 19621132
    [Abstract] [Full Text] [Related]

  • 27. Suppression of host immune response by the core protein of hepatitis C virus: possible implications for hepatitis C virus persistence.
    Large MK, Kittlesen DJ, Hahn YS.
    J Immunol; 1999 Jan 15; 162(2):931-8. PubMed ID: 9916717
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31. Vaccination of chimpanzees with plasmid DNA encoding the hepatitis C virus (HCV) envelope E2 protein modified the infection after challenge with homologous monoclonal HCV.
    Forns X, Payette PJ, Ma X, Satterfield W, Eder G, Mushahwar IK, Govindarajan S, Davis HL, Emerson SU, Purcell RH, Bukh J.
    Hepatology; 2000 Sep 15; 32(3):618-25. PubMed ID: 10960458
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. [Immunogenicity of new DNA vaccine encoding for hepatitis B virus core antigen].
    Xing YP, Huang ZH, Wang SX, Cai J, Li J, Lu S.
    Zhonghua Gan Zang Bing Za Zhi; 2004 Jun 15; 12(6):338-40. PubMed ID: 15225426
    [Abstract] [Full Text] [Related]

  • 34. DNA prime-canarypox boost with polycistronic hepatitis C virus (HCV) genes generates potent immune responses to HCV structural and nonstructural proteins.
    Pancholi P, Liu Q, Tricoche N, Zhang P, Perkus ME, Prince AM.
    J Infect Dis; 2000 Jul 15; 182(1):18-27. PubMed ID: 10882577
    [Abstract] [Full Text] [Related]

  • 35. Enhancement of the immune response generated against hepatitis C virus envelope proteins after DNA vaccination with polyprotein-encoding plasmids.
    Dueñas-Carrera S, Alvarez-Lajonchere L, César Alvarez-Obregón J, Pérez A, Acosta-Rivero N, Vázquez DM, Martínez G, Viña A, Pichardo D, Morales J.
    Biotechnol Appl Biochem; 2002 Jun 15; 35(3):205-12. PubMed ID: 12074699
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.